Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q3 2023 · 10-Q
Revenue$1.56M$1.56M+8.7% vs Q3 2022 Net Income-$5.18M-$5.18MN/M vs Q3 2022 EPS Diluted-$0.15-$0.15N/M vs Q3 2022 Gross Profit$438,000+19.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Operating Cash Flowderived-$4,043,000N/M Free Cash Flowderived-$4,139,000N/M Margins · derivedGross margin28.1%+2.6 pt vs Q3 2022
Operating margin-362.4%−40.3 pt vs Q3 2022
Net margin-332.8%−16.3 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 6, 2023 · 37 d after period end